Merus

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merus and other ETFs, options, and stocks.

About MRUS

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors.

CEO

Sven Ante Lundberg

CEOSven Ante Lundberg

Employees

260

Employees260

Headquarters

Utrecht, Utrecht

HeadquartersUtrecht, Utrecht

Founded

2003

Founded2003

Employees

260

Employees260

MRUS Key Statistics

Market cap

3.40B

Market cap3.40B

Price-Earnings ratio

-14.83

Price-Earnings ratio-14.83

Dividend yield

—

Dividend yield—

Average volume

747.27K

Average volume747.27K

High today

—

High today—

Low today

—

Low today—

Open price

$47.66

Open price$47.66

Volume

0.00

Volume0.00

52 Week high

$61.61

52 Week high$61.61

52 Week low

$37.77

52 Week low$37.77

Analyst ratings

100%

of 20 ratings

Buy

100%

Hold

Sell

Merus

Why Robinhood?

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. Show more

MRUS Key Statistics

Analyst ratings

100%

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors.